Month: September 2015

FDA approves two new diabetes drugs

FDA  has cleared two new drugs, insulin degludec injection (Tresiba—Novo Nordisk) and insulin degludec/insulin aspart injection (Ryzodeg 70/30—Novo Nordisk), for adults with diabetes. Insulin degludec injection, a long-acting insulin analog, was approved to improve glycemic control in adults with type 1 and type 2 diabetes. The drug is administered subcutaneously once a day. Insulin degludec/insulin …

FDA approves two new diabetes drugs Read More »

FDA warns about pain pill in kids

The Food and Drug Administration says it’s investigating the use of a pain pill called tramadol in children and teens under the age of 17 because some of them can develop dangerously slow breathing. The drug’s not approved for use in children but the FDA says doctors often prescribe it to them anyway. Such “off-label” …

FDA warns about pain pill in kids Read More »

FDA approves new oral medication to treat patients with advanced colorectal cancer

The U.S. Food and Drug Administration today approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with an advanced form of colorectal cancer who are no longer responding to other therapies. “The past decade has brought a new understanding around colorectal cancer, in how we can both detect and treat this …

FDA approves new oral medication to treat patients with advanced colorectal cancer Read More »

AbbVie Seeks FDA Approval for Imbruvica’s Label Expansion

Imbruvica is already approved in the U.S. for the treatment of patients with mantle cell lymphoma or CLL who have received at least one previous therapy and for CLL patients (treatment naïve) with del 17p. It is also approved for the treatment of patients with Waldenstrom’s macroglobulinemia. We remind investors that Imbruvica was added to …

AbbVie Seeks FDA Approval for Imbruvica’s Label Expansion Read More »

Update on pregnancy, lactation drug labeling after FDA ruling

A significant change to the labeling of many drug products officially occurred June 30, when a final rule issued by the FDA, the Pregnancy and Lactation Labeling Rule, became effective. This rule applies only to drug products available in the United States by prescription and does not affect the labeling of drug products available over-the-counter.e …

Update on pregnancy, lactation drug labeling after FDA ruling Read More »

FDA Panel Votes Against Painkiller From OxyContin Maker

Federal health advisers have overwhelmingly voted against a proposed painkiller from the maker of OxyContin due to risks of overdose. Purdue Pharma is seeking FDA approval to market a harder-to-abuse version of the immediate-release drug oxycodone. The company already sells an extended-release formulation of the drug OxyContin, which is designed to thwart crushing or snorting. But Food …

FDA Panel Votes Against Painkiller From OxyContin Maker Read More »

Ergonomic Stool

Puncture proof ergonomic chair. Contoured seat and back provide comfortable support. Puncture and tear resistant black polyurethane foam with tough outer self-skin performs maintenance free in tough environments. Independent seat and back tilt angle adjustment allow personalized positioning. Backrest features 35″ to 42″H and 2″D adjustments. 16″ to 21″ pneumatic seat height adjust. Seat: 18-1/2″W …

Ergonomic Stool Read More »

PARTICLE COUNTER

Kit includes everything you need: 3 channel laser diode particle counter w/internal pump. 0.3um- 5.0um Good to ISO 4. NIST traceable. Computer download software and USB cable Isokinetic Probe. Calibration Filters Rechargeable batteries (4.5 hour constant use life), charger and AC adapter. Lockable Hardened Carrying case for all components. Huge 8 Line COLOR display. Internal …

PARTICLE COUNTER Read More »